{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:31Z","timestamp":1791258871394,"version":"4.1.0"},"reference-count":43,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5551\/jat.30155","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T22:07:24Z","timestamp":1457561244000},"page":"1178-1187","source":"Crossref","is-referenced-by-count":52,"title":["Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence"],"prefix":"10.5551","volume":"23","author":[{"given":"Mari","family":"Hangai","sequence":"first","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Takebe","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Honma","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Chida","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirobumi","family":"Togashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyuki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Oda","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizue","family":"Matsui","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yashiro","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kajiwara","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Iwate Prefectural University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, NTT East Tohoku Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035- 2038","DOI":"10.1001\/jama.1979.03290450033020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, Iida M, Kiyohara Y: Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010; 41: 203-209","DOI":"10.1161\/STROKEAHA.109.564708"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA: Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-1345","DOI":"10.1056\/NEJMoa072100"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Elkeles RS: Coronary artery calcium and cardiovascular risk in diabetes. Atherosclerosis 2010; 210: 331-336","DOI":"10.1016\/j.atherosclerosis.2009.11.026"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Yamamoto H, Kitagawa T, Kihara Y: Clinical implications of the coronary artery calcium score in Japanese patients. J Atheroscler Thromb 2014; 21: 1101-1108","DOI":"10.5551\/jat.26427"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ono M, Takebe N, Oda T, Nakagawa R, Matsui M, Sasai T, Nagasawa K, Honma H, Kajiwara T, Taneichi H, Takahashi Y, Takahashi K, Satoh J: Association of coronary artery calcification with MDA-LDL-C\/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes. Intern Med 2014; 53: 391-396","DOI":"10.2169\/internalmedicine.53.9549"},{"key":"7","unstructured":"7) Sasai T, Takebe N, Ono M, Matsui M, Honma H, Fujiwara F, Kajiwara T, Taneichi H, Takahashi K, Satoh J: Coronary artery calcification to assess coronary heart disease risk inJapanese patient with type 2 diadetes. J Iwate Med Assoc 2012; 64: 363-369"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 1995; 44: 824-829","DOI":"10.2337\/diab.44.7.824"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamagishi S, Imaizumi T: Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 2005; 11: 2279-2299","DOI":"10.2174\/1381612054367300"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Myint KM, Yamamoto Y, Sakurai S, Harashima A, Watanabe T, Li H, Takeuchi A, Yoshimura K, Yonekura H, Yamamoto H: Blockade of diabetic vascular injury by controlling of AGE-RAGE system. Curr Drug Targets 2005; 6: 447-452","DOI":"10.2174\/1389450054021882"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, Schalkwijk CG: Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. J Clin Endocrinol Metab 2013; 98: E1369-1373","DOI":"10.1210\/jc.2013-1068"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S: Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999; 48: 870-880","DOI":"10.2337\/diabetes.48.4.870"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hricik DE, Wu YC, Schulak A, Friedlander MA: Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 1996; 10: 568-573","DOI":"10.1111\/j.1399-0012.1996.tb00747.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324-1330","DOI":"10.1007\/s00125-004-1451-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ: Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3687-3693","DOI":"10.1681\/ASN.2005020144"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Arsov S, Graaff R, van Oeveren W, Stegmayr B, Sikole A, Rakhorst G, Smit AJ: Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med 2014; 52: 11-20","DOI":"10.1515\/cclm-2012-0832"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30: 107-112","DOI":"10.2337\/dc06-1391"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Conway B, Edmundowicz D, Matter N, Maynard J, Orchard T: Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010; 12: 339-345","DOI":"10.1089\/dia.2009.0152"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008; 31: 517-521","DOI":"10.2337\/dc07-1755"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Nakayama M, Miyata T, Watanabe T: Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Diabet Med 2012; 29: 492-500","DOI":"10.1111\/j.1464-5491.2011.03448.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sugisawa E, Miura J, Iwamoto Y, Uchigata Y: Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes. Diabetes Care 2013; 36: 2339-2345","DOI":"10.2337\/dc12-1077"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) de Ranitz-Greven WL, Bos DC, Poucki WK, Visser GH, Beulens JW, Biesma DH, de Valk HW: Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy. Diabetes Technol Ther 2012; 14: 43-49","DOI":"10.1089\/dia.2011.0105"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yue X, Hu H, Koetsier M, Graaff R, Han C: Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med 2011; 28: 818-823","DOI":"10.1111\/j.1464-5491.2010.03217.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Okimoto H, Ishigaki Y, Koiwa Y, Hinokio Y, Ogihara T, Suzuki S, Katagiri H, Ohkubo T, Hasegawa H, Kanai H, Oka Y: A novel method for evaluating human carotid artery elasticity: possible detection of early stage atherosclerosis in subjects with type 2 diabetes. Atherosclerosis 2008; 196: 391-397","DOI":"10.1016\/j.atherosclerosis.2006.11.020"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tanaka K, Nakayama M, Kanno M, Kimura H, Watanabe K, Tani Y, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Sato K, Miyata T, Watanabe T: Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study. PLoS One 2013; 8: e83799","DOI":"10.1371\/journal.pone.0083799"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kunita E, Yamamoto H, Kitagawa T, Ohashi N, Oka T, Utsunomiya H, Urabe Y, Tsushima H, Awai K, Budoff MJ, Kihara Y: Prognostic value of coronary artery calcium and epicardial adipose tissue assessed by non-contrast cardiac computed tomography. Atherosclerosis 2014; 233: 447-453","DOI":"10.1016\/j.atherosclerosis.2014.01.038"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Bos DC, de Ranitz-Greven WL, de Valk HW: Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review. Diabetes Technol Ther 2011; 13: 773-779","DOI":"10.1089\/dia.2011.0034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lutgers HL, Graaff R, de Vries R, Smit AJ, Dullaart RP: Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. Eur J Clin Invest 2010; 40: 812-817","DOI":"10.1111\/j.1365-2362.2010.02329.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) den Dekker MA, Zwiers M, van den Heuvel ER, de Vos LC, Smit AJ, Zeebregts CJ, Oudkerk M, Vliegenthart R, Lefrandt JD, Mulder DJ: Skin autofluorescence, a noninvasive marker for AGE accumulation, is associated with the degree of atherosclerosis. PLoS One 2013; 8: e83084","DOI":"10.1371\/journal.pone.0083084"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW: Skin autofluorescence associates with vascular calcification in chronic kidney disease. Arterioscler Thromb Vasc Biol 2014; 34: 1784-1790","DOI":"10.1161\/ATVBAHA.114.303378"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Katoh T, Miyata T, Watanabe T: Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients. Nephrol Dial Transplant 2011; 26: 214-220","DOI":"10.1093\/ndt\/gfq369"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kimura H, Tanaka K, Kanno M, Watanabe K, Hayashi Y, Asahi K, Suzuki H, Sato K, Sakaue M, Terawaki H, Nakayama M, Miyata T, Watanabe T: Skin autofluorescence predicts cardiovascular mortality in patients on chronic hemodialysis. Ther Apher Dial 2014; 18: 461-467","DOI":"10.1111\/1744-9987.12160"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with endstage renal failure. Kidney Int 1997; 51: 1170-1181","DOI":"10.1038\/ki.1997.160"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tanaka K, Katoh T, Asai J, Nemoto F, Suzuki H, Asahi K, Sato K, Sakaue M, Miyata T, Watanabe T: Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients. Ther Apher Dial 2010; 14: 334-340","DOI":"10.1111\/j.1744-9987.2009.00782.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Matsumoto T, Tsurumoto T, Baba H, Osaki M, Enomoto H, Yonekura A, Shindo H, Miyata T: Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatol Int 2007; 28: 157-160","DOI":"10.1007\/s00296-007-0408-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Vouillarmet J, Maucort-Boulch D, Michon P, Thivolet C: Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration. Diabetes Technol Ther 2013; 15: 601-605","DOI":"10.1089\/dia.2013.0009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kouidrat Y, Amad A, Desailloud R, Diouf M, Fertout E, Scoury D, Lalau JD, Loas G: Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia. J Psychiatr Res 2013; 47: 1044-1048","DOI":"10.1016\/j.jpsychires.2013.03.016"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Spauwen PJ, van Eupen MG, Kohler S, Stehouwer CD, Verhey FR, van der Kallen CJ, Sep SJ, Koster A, Schaper NC, Dagnelie PC, Schalkwijk CG, Schram MT, van Boxtel MP: Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study. J Clin Endocrinol Metab 2015; 100: 951-960","DOI":"10.1210\/jc.2014-2754"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Yamagishi S, Nakamura K, Matsui T: Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPARgamma)-modulating activity for the treatment of cardiometabolic disorders. Curr Mol Med 2007; 7: 463-469","DOI":"10.2174\/156652407781387073"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A: Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005; 1043: 290-298","DOI":"10.1196\/annals.1333.036"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Yoshida N, Okumura K, Aso Y: High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 2005; 54: 345-350","DOI":"10.1016\/j.metabol.2004.09.014"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, Carr JJ, Budoff MJ, Allison MA: Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014; 311: 271-278","DOI":"10.1001\/jama.2013.282535"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/10\/23_30155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:22:30Z","timestamp":1748802150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/10\/23_30155\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.30155","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}